Related Experiment Video
Updated: May 22, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Intercellular contractile force attenuates chemosensitivity through Notch-MVP-mediated nuclear drug export
Abstract:
Resistance to chemotherapeutics is one major challenge to clinical effectiveness of cancer treatment and is primarily interpreted by various biochemical mechanisms. This study establishes an inverse correlation between tumor cell contractility and chemosensitivity. In both clinical biopsies and cancer cell lines, high/low actomyosin-mediated contractile force attenuates/enhances the vulnerability to chemotherapy, which depends on intercellular force propagation. Cell-cell interaction force activates the mechanosensitive Notch signaling that upregulates the downstream effector major vault protein, which facilitates the export of chemotherapy drugs from nuclei, leading to the reduction of chemosensitivity. Cellular contractility promotes the tolerance of tumor xenografts to chemotherapy and sustains tumor growth in vivo, which can be reversed by the inhibition of contractile force, Notch signaling, or major vault protein. Further, the actomyosin-Notch signaling is associated with drug resistance and cancer recurrence of patients. These findings unveil a regulatory role of intercellular force in chemosensitivity, which could be harnessed as a promising target for cancer mechanotherapeutics.
Insights
Tumor cell contractility inversely affects chemotherapy sensitivity. High contractile force reduces drug effectiveness by activating Notch signaling and major vault protein, increasing drug resistance.
Area of Science:
- Oncology
- Biophysics
- Cell Biology
Background:
- Chemotherapeutic resistance is a major obstacle in cancer treatment, often attributed to biochemical mechanisms.
- Understanding novel regulatory pathways beyond traditional biochemistry is crucial for improving treatment efficacy.
Purpose of the Study:
- To investigate the correlation between tumor cell contractility and chemosensitivity.
- To elucidate the molecular mechanisms linking cellular contractility to drug resistance.
- To explore the potential of targeting cellular contractility for cancer therapy.
Main Methods:
- Analysis of clinical biopsies and cancer cell lines.
- Measurement of actomyosin-mediated contractile force and intercellular force propagation.
- Investigation of Notch signaling pathway activation and major vault protein expression.
- In vivo studies using tumor xenografts and assessment of therapeutic interventions.
Main Results:
- An inverse correlation was found between tumor cell contractility and chemosensitivity.
- High actomyosin-mediated contractile force attenuates chemotherapy vulnerability via intercellular force propagation.
- Cell-cell interaction activates Notch signaling, upregulating major vault protein and promoting drug export from nuclei.
- Inhibition of contractile force, Notch signaling, or major vault protein reversed tumor tolerance to chemotherapy in vivo.
- Actomyosin-Notch signaling is linked to patient drug resistance and cancer recurrence.
Conclusions:
- Intercellular force and cellular contractility play a regulatory role in chemotherapy sensitivity.
- The actomyosin-Notch signaling pathway is a key mediator of chemoresistance.
- Targeting cellular contractility and associated signaling pathways offers a promising avenue for novel cancer mechanotherapeutics.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Regulation of Nuclear Protein Sorting
Treatment Resistant Cancers
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...

